Deal announcement

goetzpartners advised Afinum 9 on its investment in Hofstetter PCB AG

22. September 2023

goetzpartners advised Afinum 9 on its investment in Hofstetter PCB AG with a Commercial Due Diligence

goetzpartners advised Afinum 9 with a Commercial Due Diligence on its investment in Hofstetter PCB AG (Hofstetter), the leading European provider of printed circuit boards plating and special final finishing services. Together with its prior investment in GS Swiss, Afinum hereby extends its stronghold in the growing electronic medical device supplier market.

In 2022, Afinum has invested in GS Swiss, a manufacturer of extremely reliable, highly miniaturized printed circuit boards with a market-leading position in the medical industry for small-to-medium volumes. Hofstetter adds crucial technological know-how and hence enforces the position of the group as a leading electronic medical device supplier. Hofstetter and GS Swiss will continue to operate as independent companies within a common group.

This project complements goetzpartners' outstanding track record in providing strategic and commercial advisory services in the space of high-tech industrial applications and specifically chips/ semiconductors and printed circuit boards (PCBs).

About Hofstetter 
Hofstetter (founded in 1980) operates with a workforce of around 80 people across three sites in Switzerland (Küssnacht am Rigi) and Germany (Lörrach, Herrenberg). The business has grown into the leading full-service provider for printed circuit board plating and special final finishing services in Europe serving customers in high-precision industries, such as the medical device market as well as in other distinct industries.

About Afinum 
Afinum Management GmbH is an independent financial investor wholly-owned by its Management with offices in Munich and Zurich, specializing in the acquisition of shareholdings in financially sound and successful mid-market companies in the German speaking region as well as in neighboring countries in Europe.

Transaction team:

Dr. Gerrit Schütte
Managing Director

David Oesterschlink

Timo Stern

Richard Nowack

Urban Maier
Associate Consultant